Skip to main content
Bristol Myers Squibb10-Q: Restructuring

BMS expands operating model restructuring targeting $2.0 billion annual savings by end of 2027

Source: Autobound Signal API · 118 signals tracked for Bristol Myers Squibb · updated

Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.

What happened

Bristol-Myers Squibb is streamlining its enterprise operating model across R&D, manufacturing, commercial, and other functions under its updated 2023 Restructuring Plan.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

Bristol Myers Squibb 10-Q for Quarter ended Mar 31, 2026

Filing excerpt

As previously announced, our ongoing strategic productivity initiative includes acceleration of the delivery of medicines to patients by evolving and streamlining our enterprise operating model in key areas such as R&D, manufacturing, commercial and other functions. As a result of an expansion in 2025, we expect to realize annual cost savings of approximately $2.0 billion by the end of 2027. The exit costs resulting from these actions are included in our updated 2023 Restructuring Plan.

sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
Apr 30, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$2B (expected annual cost savings by the end of 2027 from ongoing strategic productivity initiative)

Details

CIK
14272
Accession number
0000014272-26-000010
Timeframe
Next two years
Quarter
Q1
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
75%
Sentiment
Neutral
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/cfc35c79-d3ea-4cc6-88e8-e7d96f36263e returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.

{
  "signal_id": "cfc35c79-d3ea-4cc6-88e8-e7d96f36263e",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-11-09T06:24:49.431+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "detail": "Bristol-Myers Squibb is streamlining its enterprise operating model across R&D, manufacturing, commercial, and other functions under its updated 2023 Restructuring Plan. Vendors providing operating model transformation and functional optimization solutions may find evaluation opportunities as the company works to achieve $2.0 billion in cost savings.",
    "metrics": {
      "timeframe": "next_two_years",
      "dollar_context": "expected annual cost savings by the end of 2027 from ongoing strategic productivity initiative",
      "dollar_millions": 2000
    },
    "quarter": "Q1",
    "summary": "BMS expands operating model restructuring targeting $2.0 billion annual savings by end of 2027",
    "excerpts": "As previously announced, our ongoing strategic productivity initiative includes acceleration of the delivery of medicines to patients by evolving and streamlining our enterprise operating model in key areas such as R&D, manufacturing, commercial and other functions. As a result of an expansion in 2025, we expect to realize annual cost savings of approximately $2.0 billion by the end of 2027. The exit costs resulting from these actions are included in our updated 2023 Restructuring Plan.",
    "relevance": 0.75,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.